Jansen Wim J J, Buma Sannine, Gootjes Jaap R G, Zuurmond Wouter W A, Perez Roberto S G M, Loer Stephan A
1 Department of Anesthesiology, VU University Medical Center , Amsterdam, The Netherlands .
J Palliat Med. 2015 Jan;18(1):67-70. doi: 10.1089/jpm.2013.0645.
The Palliative Performance Scale (PPS) is a tool that is widely used to predict end of life. In Ontario, Canada, the PPS is used to mark the terminal phase of life and eligibility for terminal care.
The aim of this retrospective study was to confirm that a PPS level of 40% can be used as a marker for the terminal phase of life.
PPS levels from 78 patients were calculated based on the intake reports made at admission to an inpatient hospice.
Although 77 patients passed away within a period of 3 months, PPS levels at admission varied from 10% to 70%. Fifty-six percent of all patients had a PPS level of 40% or less. Regarding survival, three significant PPS profiles, consisting of two or more PPS levels could be distinguished.
姑息治疗表现量表(PPS)是一种广泛用于预测生命终结的工具。在加拿大安大略省,PPS用于标记生命终末期以及终末护理资格。
这项回顾性研究的目的是确认PPS水平达到40%可作为生命终末期的一个标志。
根据住院临终关怀机构入院时的接诊报告计算78例患者的PPS水平。
尽管77例患者在3个月内离世,但入院时的PPS水平从10%到70%不等。所有患者中有56%的PPS水平为40%或更低。关于生存情况,可以区分出由两个或更多PPS水平组成的三种显著的PPS概况。